Table of Content

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. INFECTIOUS DISEASE TESTING KIT IS THE FASTEST GROWING PRODUCT TYPE DURING THE FORECAST PERIOD
3.2.2. PROFESSIONAL DIAGNOSTIC CENTERS ARE THE MAJOR END-USER IN POINT OF CARE MARKET
3.2.3. PRESCRIPTION BASED DEVICES ARE THE FREQUENTLY USED MODE OF PRESCRIPTION

4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. GROWING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES
4.2.2. RISE IN THE IMPLEMENTATION OF HEALTHCARE REFORMS
4.2.3. RISING DEMAND FOR DECENTRALIZED CHRONIC AND INFECTIOUS DISEASE TESTING
4.3. MARKET RESTRAINTS
4.3.1. STRINGENT REGULATION
4.3.2. INSUFFICIENT REIMBURSEMENT POLICIES
4.4. MARKET OPPORTUNITIES
4.4.1. REDUCTION IN THE HEALTHCARE COST FACILITATES
4.4.2. RISING INCIDENCES AND PREVALENCE RATES OF VARIOUS INFECTIOUS DISEASES
4.4.3. GROWING NUMBER OF SMARTPHONE EMPOWERS PATIENTS TO MONITOR THEIR CLINICAL CONDITION ONLINE
4.5. MARKET CHALLENGES
4.5.1. CHALLENGES RELATED TO THE EXECUTION OF HIGHLY SENSITIVE DEVICES
4.5.2. VARIATION IN TEST RESULTS
4.5.3. DIFFICULTIES ASSOCIATED IN DATA MANAGEMENT

5. MARKET BY MODE OF PRESCRIPTION
5.1. PRESCRIPTION BASED DEVICES
5.2. OTC BASED DEVICES

6. MARKET BY END-USER
6.1. PROFESSIONAL DIAGNOSTIC CENTERS
6.2. RESEARCH LABORATORIES
6.3. HOME CARE
6.4. OTHER END-USER

7. MARKET BY PRODUCT TYPE
7.1. GLUCOSE MONITORING KITS
7.2. INFECTIOUS DISEASES TESTING KITS
7.3. PREGNANCY AND FERTILITY TESTING KITS
7.4. HEMATOLOGY TESTING KITS
7.5. CARDIOMETABOLIC MONITORING KITS
7.6. URINALYSIS TESTING KITS
7.7. COAGULATION MONITORING KITS
7.8. TUMOR/CANCER MARKERS TESTING KITS
7.9. CHOLESTEROL TESTING TRIPS
7.10. DRUGS OF ABUSE TESTING KITS
7.11. FECAL OCCULT TESTING KITS
7.12. OTHER PRODUCT

8. KEY ANALYTICS
8.1. PORTER’S FIVE FORCES MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE
8.1.3. BARGAINING POWER OF BUYERS
8.1.4. BARGAINING POWER OF SUPPLIERS
8.1.5. THREAT OF COMPETITIVE RIVALRY
8.2. POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL ANALYSIS
8.3. REGULATORY FRAMEWORK
8.4. PATENT ANALYSIS
8.5. ETYMOLOGY OF POINT OF CARE MARKET
8.6. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. THE UNITED STATES
9.1.2. CANADA

10. COMPANY PROFILES
10.1. ABBOTT
10.2. BECTON DICKINSON AND COMPANY
10.3. BIOM?RIEUX SA
10.4. BIO-RAD LABORATORIES, INC.
10.5. CARDINAL HEALTH INC.
10.6. CHEMBIO DIAGNOST ICS SYSTEMS, INC.
10.7. DANAHER CORPORATION
10.8. GENE POC
10.9. F. HOFFMANN-LA ROCHE LTD.
10.10. ORTHO CLINICAL DIAGNOSTICS
10.11. QUEST DIAGNOSTICS INC.
10.12. SIEMENS HEALTHINEERS
10.13. SIGHT DIAGNOSTICS LTD.
10.14. THERMO FISHER SCIENTIFIC INC.
10.15. TRINITY BIOTECH
10.16. TRIVITRON HEALTHCARE

TABLE LIST
TABLE 1 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
TABLE 2 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY MODE OF PRESCRIPTION 2019-2027 ($ MILLION)
TABLE 3 NORTH AMERICA PRESCRIPTION BASED DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 4 NORTH AMERICA OTC BASED DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS MARKET 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA RESEARCH LABORATORIES MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA HOME CARE MARKET 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA OTHER END-USER MARKET 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY PRODUCT TYPE 2019-2027 ($ MILLION)
TABLE 11 NORTH AMERICA GLUCOSE MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA INFECTIOUS DISEASES TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA PREGNANCY AND FERTILITY TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA HEMATOLOGY TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA CARDIOMETABOLIC MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA URINALYSIS TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA COAGULATION MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 18 NORTH AMERICA TUMOR/CANCER MARKERS TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA CHOLESTEROL TESTING TRIPS MARKET 2019-2027 ($ MILLION)
TABLE 20 NORTH AMERICA DRUGS OF ABUSE TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 21 NORTH AMERICA FECAL OCCULT TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 22 NORTH AMERICA OTHER PRODUCT MARKET 2019-2027 ($ MILLION)
TABLE 23 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY COUNTRY 2019-2027 ($ MILLION)


FIGURES LIST
FIGURE 1 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 2 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET SHARE BY MODE OF PRESCRIPTION 2018 & 2027 (%)
FIGURE 3 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY PRESCRIPTION BASED DEVICES 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY OTC BASED DEVICES 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 6 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY PROFESSIONAL DIAGNOSTIC CENTERS 2019-2027 ($ MILLION)
FIGURE 7 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY RESEARCH LABORATORIES 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY HOME CARE 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 10 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET SHARE BY PRODUCT TYPE 2018 & 2027 (%)
FIGURE 11 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY GLUCOSE MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY INFECTIOUS DISEASES TESTING KITS 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY PREGNANCY AND FERTILITY TESTING KITS 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY HEMATOLOGY TESTING KITS 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY CARDIOMETABOLIC MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY URINALYSIS TESTING KITS 2019-2027 ($ MILLION)
FIGURE 17 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY COAGULATION MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 18 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY TUMOR/CANCER MARKERS TESTING KITS 2019-2027 ($ MILLION)
FIGURE 19 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY CHOLESTEROL TESTING TRIPS 2019-2027 ($ MILLION)
FIGURE 20 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY DRUGS OF ABUSE TESTING KITS 2019-2027 ($ MILLION)
FIGURE 21 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY FECAL OCCULT TESTING KITS 2019-2027 ($ MILLION)
FIGURE 22 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY OTHER PRODUCT 2019-2027 ($ MILLION)
FIGURE 23 PORTER’S FIVE FORCE MODEL
FIGURE 24 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 25 THE UNITED STATES POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 26 CANADA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)



List of Figures


FIGURES LIST
FIGURE 1 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 2 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET SHARE BY MODE OF PRESCRIPTION 2018 & 2027 (%)
FIGURE 3 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY PRESCRIPTION BASED DEVICES 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY OTC BASED DEVICES 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 6 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY PROFESSIONAL DIAGNOSTIC CENTERS 2019-2027 ($ MILLION)
FIGURE 7 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY RESEARCH LABORATORIES 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY HOME CARE 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 10 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET SHARE BY PRODUCT TYPE 2018 & 2027 (%)
FIGURE 11 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY GLUCOSE MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY INFECTIOUS DISEASES TESTING KITS 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY PREGNANCY AND FERTILITY TESTING KITS 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY HEMATOLOGY TESTING KITS 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY CARDIOMETABOLIC MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY URINALYSIS TESTING KITS 2019-2027 ($ MILLION)
FIGURE 17 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY COAGULATION MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 18 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY TUMOR/CANCER MARKERS TESTING KITS 2019-2027 ($ MILLION)
FIGURE 19 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY CHOLESTEROL TESTING TRIPS 2019-2027 ($ MILLION)
FIGURE 20 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY DRUGS OF ABUSE TESTING KITS 2019-2027 ($ MILLION)
FIGURE 21 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY FECAL OCCULT TESTING KITS 2019-2027 ($ MILLION)
FIGURE 22 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY OTHER PRODUCT 2019-2027 ($ MILLION)
FIGURE 23 PORTER’S FIVE FORCE MODEL
FIGURE 24 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 25 THE UNITED STATES POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 26 CANADA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

 

List of Tables


TABLE LIST
TABLE 1 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
TABLE 2 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY MODE OF PRESCRIPTION 2019-2027 ($ MILLION)
TABLE 3 NORTH AMERICA PRESCRIPTION BASED DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 4 NORTH AMERICA OTC BASED DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS MARKET 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA RESEARCH LABORATORIES MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA HOME CARE MARKET 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA OTHER END-USER MARKET 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY PRODUCT TYPE 2019-2027 ($ MILLION)
TABLE 11 NORTH AMERICA GLUCOSE MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA INFECTIOUS DISEASES TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA PREGNANCY AND FERTILITY TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA HEMATOLOGY TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA CARDIOMETABOLIC MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA URINALYSIS TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA COAGULATION MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 18 NORTH AMERICA TUMOR/CANCER MARKERS TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA CHOLESTEROL TESTING TRIPS MARKET 2019-2027 ($ MILLION)
TABLE 20 NORTH AMERICA DRUGS OF ABUSE TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 21 NORTH AMERICA FECAL OCCULT TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 22 NORTH AMERICA OTHER PRODUCT MARKET 2019-2027 ($ MILLION)
TABLE 23 NORTH AMERICA POINT OF CARE DIAGNOSTICS MARKET BY COUNTRY 2019-2027 ($ MILLION)